Testing effectiveness (Phase 2)UnknownNCT05076851
What this trial is testing
Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy(ADT)for High Risk Prostate Cancer
Who this might be right for
Neoadjuvant Therapy \High Risk Prostate Cancer
Hongqian Guo 2